—New service ensures rapid delivery of small volume clinical trial materials, solving a critical bottleneck in drug development— SPOKANE, Wash.--(BUSINESS WIRE)--Selkirk Pharma, Inc., a privately held ...
Dublin, March 12, 2026 (GLOBE NEWSWIRE)-- The "Biologics Fill Finish Manufacturing Market: Industry Trends and Global Forecasts, Till 2035" report has been added to ResearchAndMarkets.com's offering.
The "Fill Finish Pharmaceutical Contract Manufacturing Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Fill Finish Service Offered, Type of FDF, API Potency, Type of ...
A booming biologics market is increasing demand for specialist fill-finish services and prompting contractors to invest in technologies that reduce waste and safeguard these sensitive medicines. The ...
Cell therapies such as CAR-T have revolutionized the biopharmaceutical industry, especially manufacturing processes. As a result, cell therapy developers are always searching for flexible solutions to ...
Fill Finish Manufacturing Market worth $28.14 billion by 2030 with 8.9% CAGR | MarketsandMarkets(TM)
The MarketWatch News Department was not involved in the creation of this content. DELRAY BEACH, Fla., Aug. 19, 2025 /PRNewswire/ -- The global Fill Finish Manufacturing Market, valued at US$16.85 ...
SPOKANE, Wash.--(BUSINESS WIRE)--Selkirk Pharma, Inc., a privately held U.S. pharmaceutical manufacturer specializing in the fill and finish of injectable drugs, including vaccines and biological ...
(MENAFN- GlobeNewsWire - Nasdaq) The biologics fill finish manufacturing market offers key opportunities through outsourcing trends, technological advancements enhancing efficiency, and growing demand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results